FPH — Fisher & Paykel Healthcare Income Statement
0.000.00%
Last trade - 00:00- NZ$20.29bn
- NZ$20.33bn
- NZ$1.74bn
Annual income statement for Fisher & Paykel Healthcare, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | NZAS | NZAS | NZAS | NZAS | NZAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,264 | 1,971 | 1,682 | 1,581 | 1,743 |
| Cost of Revenue | |||||
| Gross Profit | 836 | 1,246 | 1,053 | 938 | 1,044 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 884 | 1,259 | 1,176 | 1,249 | 1,488 |
| Operating Profit | 379 | 712 | 506 | 332 | 255 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 371 | 718 | 504 | 328 | 236 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 287 | 524 | 377 | 250 | 133 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 287 | 524 | 377 | 250 | 133 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 287 | 524 | 377 | 250 | 133 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.496 | 0.904 | 0.65 | 0.43 | 0.32 |
| Dividends per Share | |||||
| Special Dividends per Share |